Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?

Chronic GVHD (cGVHD) is an important problem after allotransplants. Some risk factors for cGVHD are similar to those of acute GVHD (aGVHD) but others are distinct indicating sometimes overlapping but unique pathogeneses. Precise incidence and prevalence data of cGVHD are lacking because of diverse d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2013-02, Vol.48 (2), p.203-209
Hauptverfasser:	Linhares, Y P L, Pavletic, S, Gale, R P
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/1904 692/699/249/1529 692/700/565/251 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Bone marrow Bone marrow transplantation Bone marrow, stem cells transplantation. Graft versus host reaction Cell Biology Chronic Disease Corticoids Corticosteroids Criteria Data processing Diagnostic systems Donors Dosage and administration Drug therapy Drugs Graft versus host reaction Graft vs Host Disease - drug therapy Graft vs Host Disease - immunology Hematology Humans Immunity Immunologic Factors - therapeutic use Immunomodulation Immunosuppressive agents Internal Medicine Medical sciences Medicine Medicine & Public Health Mortality Physiological aspects Public Health review Reviews Risk analysis Risk factors Side effects Stem cell transplantation Stem Cells Thalidomide Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!